The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
22 | 86 | 73 | 87 |
Growth
|
91 | 35 | 59 | 65 |
Safety
|
39 | 39 | 4 | 13 |
Sentiment
|
69 | 43 | 82 | 3 |
|
94 | 94 | 70 | 29 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Analyst Opinions
|
67 | 73 | 54 | 29 |
Opinions Change
|
82 | 50 | 100 | 2 |
Pro Holdings
|
n/a | 31 | 31 | 31 |
Market Pulse
|
58 | 17 | 43 | 42 |
Sentiment
|
69 | 43 | 82 | 3 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
22 | 86 | 73 | 87 |
Growth
|
91 | 35 | 59 | 65 |
|
39 | 39 | 4 | 13 |
Combined
|
89 | 89 | 51 | 55 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Price vs. Sales (P/S)
|
52 | 52 | 52 | 52 |
Price vs. Earnings (P/E)
|
38 | 89 | 78 | 66 |
Price vs. Book (P/B)
|
20 | 91 | 72 | 77 |
Dividend Yield
|
1 | 1 | 1 | 1 |
Value
|
22 | 86 | 73 | 87 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue Growth
|
88 | 45 | 63 | 47 |
Profit Growth
|
93 | 55 | 90 | 56 |
Capital Growth
|
1 | 58 | 49 | 91 |
Stock Returns
|
99 | 9 | 11 | 23 |
Growth
|
91 | 35 | 59 | 65 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Leverage
|
39 | 50 | 53 | 54 |
Refinancing
|
25 | 12 | 13 | 25 |
Liquidity
|
1 | 1 | 4 | 18 |
|
39 | 39 | 4 | 13 |
Discover high‑ranked alternatives to ImmunoPrecise Antibodies and broaden your portfolio horizons.
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.